Document ID: chunk:federal_register_of_legislation:F2025C00217:reg:8
Version: federal_register_of_legislation:F2025C00217
Segment Type: reg
Provision Reference: reg 8
Character Range: 4567–6017

8  Commonwealth payment of special patient contribution
 (1) For the purposes of subsection 85B(4) of the Act, the circumstances in which the Commonwealth is to pay the special patient contribution for a brand of a pharmaceutical item are:
 (a) the brand of pharmaceutical item is mentioned in Schedule 2 to this instrument; and
 (b) the brand has been prescribed in a circumstance mentioned for the brand in Schedule 2 to this instrument; and
 (c)  either:
 (i) writing the prescription has been authorised in accordance with section 19 of the National Health (Listing of Pharmaceutical Benefits) Instrument 2024; or
 (ii) if the circumstances are not ones in which writing the prescription requires authorisation—the prescription satisfies the requirements of subsection (2).
 (2) A prescription satisfies the requirements of this subsection if:
 (a) the prescription or details of the prescription are submitted to the Chief Executive Medicare; and
 (b) the Chief Executive Medicare authorises the prescription for the purposes of payment of the special patient contribution and allots a number to the prescription; and
 (c) the allotted number is written on the prescription.
 (3) For the purposes of this section, the pharmaceutical item is the listed drug mentioned in Schedule 2:
 (a) in the form mentioned in Schedule 2 for the listed drug; and
 (b) with the manner of administration mentioned in Schedule 2 for the form of the listed drug.